Back
Results - Announcements
Sales rise 22.83% to Rs 251.82 crore
Gufic BioSciences consolidated net profit rises 183.68% in the March 2026 quarter
01-Jun-2026, 07:26
Net profit of Gufic BioSciences rose 183.68% to Rs 21.90 crore in the quarter ended March 2026 as against Rs 7.72 crore during the previous quarter ended March 2025. Sales rose 22.83% to Rs 251.82 crore in the quarter ended March 2026 as against Rs 205.02 crore during the previous quarter ended March 2025.
Net profit of Gufic BioSciences rose 183.68% to Rs 21.90 crore in the quarter ended March 2026 as against Rs 7.72 crore during the previous quarter ended March 2025. Sales rose 22.83% to Rs 251.82 crore in the quarter ended March 2026 as against Rs 205.02 crore during the previous quarter ended March 2025.
For the full year,net profit declined 7.81% to Rs 64.21 crore in the year ended March 2026 as against Rs 69.65 crore during the previous year ended March 2025. Sales rose 15.15% to Rs 944.01 crore in the year ended March 2026 as against Rs 819.81 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 251.82 | 205.02 | 23 | 944.01 | 819.81 | 15 |
| OPM % | 18.75 | 12.87 | - | 16.03 | 16.60 | - |
| PBDT | 36.60 | 18.37 | 99 | 117.38 | 115.21 | 2 |
| PBT | 28.95 | 10.52 | 175 | 86.55 | 94.14 | -8 |
| NP | 21.90 | 7.72 | 184 | 64.21 | 69.65 | -8 |
Powered by Capital Market - Live News
